ABSTRACT
With the emergence and wide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs), such as the Delta variant (B.1.617.2 lineage and AY sublineage), it is important to track VOCs for sourcing of transmission. Currently, whole-genome sequencing is commonly used for detecting VOCs, but this is limited by the high costs of reagents and sophisticated sequencers. In this study, common mutations in the genomes of SARS-CoV-2 VOCs were identified by analyzing more than 1 million SARS-CoV-2 genomes from public data. Among them, mutations C1709A (a change of C to A at position 1709) and C56G, respectively, were found in more than 99% of the genomes of Alpha and Delta variants and were specific to them. Then, a method using the amplification refractory mutation system combined with quantitative reverse transcription-PCR (ARMS-RT-qPCR) based on the two mutations was developed for identifying both VOCs. The assay can detect as little as 1 copy/µL of the VOCs, and the results for identifying Alpha and Delta variants in clinical samples by the ARMS-RT-qPCR assay showed 100% agreement with the results using sequencing-based methods. The whole assay can be completed in 2.5 h using commercial fluorescent PCR instruments. Therefore, the ARMS-RT-qPCR assay could be used for screening the two highly concerning variants Alpha and Delta by normal PCR laboratories in airports and in hospitals and other health-related organizations. Additionally, based on the unique mutations identified by the genomic analysis, similar molecular assays can be developed for rapid identification of other VOCs. IMPORTANCE The current stage of the pandemic, led by SARS-CoV-2 variants of concern (VOCs), underscores the necessity to develop a cost-effective and rapid molecular diagnosis assay to differentiate the VOCs. In this study, over 1 million SARS-CoV-2 genomic sequences of high quality from GISAID were analyzed and a network of the common mutations of the lineages was constructed. The conserved unique mutations specific for SARS-CoV-2 VOCs were found. Then, ARMS-RT-qPCR assays based on the two unique mutations of the Alpha and Delta variants were developed for the detection of the two VOCs. Application of the assay in clinical samples demonstrated that the current method is a convenient, cost-effective, and rapid way to screen the target SARS-CoV-2 VOCs.
Subject(s)
COVID-19/virology , Nucleic Acid Amplification Techniques/methods , SARS-CoV-2/genetics , Genome, Viral , High-Throughput Nucleotide Sequencing , Mutation , Nucleic Acid Amplification Techniques/trends , Pharynx/virology , RNA, Viral/isolation & purification , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , SARS-CoV-2/classification , Spike Glycoprotein, Coronavirus/chemistry , Spike Glycoprotein, Coronavirus/classification , Spike Glycoprotein, Coronavirus/geneticsABSTRACT
Early detection of viral pathogens by DNA-sensors in clinical samples, contaminated foods, soil or water can dramatically improve clinical outcomes and reduce the socioeconomic impact of diseases such as COVID-19. Clustered regularly interspaced short palindromic repeat (CRISPR) and its associated protein Cas12a (previously known as CRISPR-Cpf1) technology is an innovative new-generation genomic engineering tool, also known as 'genetic scissors', that has demonstrated the accuracy and has recently been effectively applied as appropriate (E-CRISPR) DNA-sensor to detect the nucleic acid of interest. The CRISPR-Cas12a from Prevotella and Francisella 1 are guided by a short CRISPR RNA (gRNA). The unique simultaneous cis- and trans- DNA cleavage after target sequence recognition at the PAM site, sticky-end (5-7 bp) employment, and ssDNA/dsDNA hybrid cleavage strategies to manipulate the attractive nature of CRISPR-Cas12a are reviewed. DNA-sensors based on the CRISPR-Cas12a technology for rapid, robust, sensitive, inexpensive, and selective detection of virus DNA without additional sample purification, amplification, fluorescent-agent- and/or quencher-labeling are relevant and becoming increasingly important in industrial and medical applications. In addition, CRISPR-Cas12a system shows great potential in the field of E-CRISPR-based bioassay research technologies. Therefore, we are highlighting insights in this research direction.
Subject(s)
CRISPR-Cas Systems/physiology , DNA, Viral/isolation & purification , Nucleic Acid Amplification Techniques , Animals , Biosensing Techniques/methods , Biosensing Techniques/trends , COVID-19/virology , DNA, Viral/analysis , Environmental Pollutants/analysis , Environmental Pollutants/isolation & purification , Food Contamination/analysis , Humans , Molecular Typing/methods , Molecular Typing/trends , Nucleic Acid Amplification Techniques/methods , Nucleic Acid Amplification Techniques/trends , SARS-CoV-2/genetics , Virology/methods , Virology/trends , Virus Diseases/classification , Virus Diseases/diagnosis , Virus Diseases/virologyABSTRACT
As one of the major approaches in combating the COVID-19 pandemics, the availability of specific and reliable assays for the SARS-CoV-2 viral genome and its proteins is essential to identify the infection in suspected populations, make diagnoses in symptomatic or asymptomatic individuals, and determine clearance of the virus after the infection. For these purposes, use of the quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) for detection of the viral nucleic acid remains the most valuable in terms of its specificity, fast turn-around, high-throughput capacity, and reliability. It is critical to update the sequences of primers and probes to ensure the detection of newly emerged variants. Various assays for increased levels of IgG or IgM antibodies are available for detecting ongoing or past infection, vaccination responses, and persistence and for identifying high titers of neutralizing antibodies in recovered individuals. Viral genome sequencing is increasingly used for tracing infectious sources, monitoring mutations, and subtype classification and is less valuable in diagnosis because of its capacity and high cost. Nanopore target sequencing with portable options is available for a quick process for sequencing data. Emerging CRISPR-Cas-based assays, such as SHERLOCK and AIOD-CRISPR, for viral genome detection may offer options for prompt and point-of-care detection. Moreover, aptamer-based probes may be multifaceted for developing portable and high-throughput assays with fluorescent or chemiluminescent probes for viral proteins. In conclusion, assays are available for viral genome and protein detection, and the selection of specific assays depends on the purposes of prevention, diagnosis and pandemic control, or monitoring of vaccination efficacy.
Subject(s)
COVID-19 Testing/methods , COVID-19/diagnosis , Pandemics , SARS-CoV-2 , Antibodies, Viral/analysis , Antigens, Viral/analysis , COVID-19/epidemiology , COVID-19/virology , COVID-19 Nucleic Acid Testing/methods , COVID-19 Nucleic Acid Testing/trends , COVID-19 Serological Testing/methods , COVID-19 Serological Testing/trends , COVID-19 Testing/trends , Genome, Viral , Humans , Molecular Diagnostic Techniques/methods , Molecular Diagnostic Techniques/trends , Mutation , Nucleic Acid Amplification Techniques/methods , Nucleic Acid Amplification Techniques/trends , Open Reading Frames , RNA, Viral/analysis , RNA, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods , Reverse Transcriptase Polymerase Chain Reaction/trends , SARS-CoV-2/classification , SARS-CoV-2/genetics , SARS-CoV-2/immunology , SARS-CoV-2/isolation & purification , Sequence Analysis, RNA/methods , Sequence Analysis, RNA/trendsABSTRACT
The world is facing lockdown for the first time in decades due to the novel coronavirus COVID-19 (SARS-CoV-2) pandemic. This has led to massive global economic disruption, placed additional strain on local and global public health resources and, above all, threatened human health. We conducted a review of peer-reviewed and unpublished data, written in English, reporting on the current COVID-19 pandemic. This data includes previously used strategies against infectious disease, recent clinical trials and FDA-approved diagnostic and treatment strategies. The literature was obtained through a systematic search using PubMed, Web of Sciences, and FDA, NIH and WHO websites. Of the 98 references included in the review, the majority focused on pathogen and host targeting, symptomatic treatment and convalescent plasma utilization. Other sources investigated vaccinations in the pipeline for the possible prevention of COVID-19 infection. The results demonstrate various conventional as well as potentially advanced in vitro diagnostic approaches (IVD) for the diagnosis of COVID-19. Mixed results have been observed so far when utilising these approaches for the treatment of COVID-19 infection. Some treatments have been found highly effective in specific regions of the world while others have not altered the disease process. The responsiveness of currently available options is not conclusive. The novelty of this disease, the rapidity of its global outbreak and the unavailability of vaccines have contributed to the global public's fear. It is concluded that the exploration of a range of diagnostic and treatment strategies for the management of COVID-19 is the need of the hour.
Subject(s)
Betacoronavirus , Coronavirus Infections/diagnosis , Coronavirus Infections/therapy , Pandemics/prevention & control , Pneumonia, Viral/diagnosis , Pneumonia, Viral/therapy , Antiviral Agents/therapeutic use , COVID-19 , Humans , Immunization, Passive/trends , Nucleic Acid Amplification Techniques/methods , Nucleic Acid Amplification Techniques/trends , Real-Time Polymerase Chain Reaction/methods , Real-Time Polymerase Chain Reaction/trends , SARS-CoV-2 , COVID-19 SerotherapyABSTRACT
Digital loop-mediated isothermal amplification (dLAMP) refers to compartmentalizing nucleic acids and LAMP reagents into a large number of individual partitions, such as microchambers and droplets. This compartmentalization enables dLAMP to be an excellent platform to quantify the absolute number of the target nucleic acids. Owing to its low requirement for instrumentation complexity, high specificity, and strong tolerance to inhibitors in the nucleic acid samples, dLAMP has been recognized as a simple and accurate technique to quantify pathogenic nucleic acid. Herein, the general process of dLAMP techniques is summarized, the current dLAMP techniques are categorized, and a comprehensive discussion on different types of dLAMP techniques is presented. Also, the challenges of the current dLAMP are illustrated together with the possible strategies to address these challenges. In the end, the future directions of the dLAMP developments, including multitarget detection, multisample detection, and processing nucleic acid extraction are outlined. With recently significant advances in dLAMP, this technology has the potential to see more widespread use beyond the laboratory in the future.
Subject(s)
Molecular Diagnostic Techniques , Nucleic Acid Amplification Techniques , Molecular Diagnostic Techniques/standards , Molecular Diagnostic Techniques/trends , Nucleic Acid Amplification Techniques/standards , Nucleic Acid Amplification Techniques/trends , Nucleic Acids/analysis , Sensitivity and SpecificityABSTRACT
MicroRNAs (MiRNAs) play multiple crucial regulating roles in cell which can regulate one third of protein-coding genes. MiRNAs participate in the developmental and physiological processes of human body, while their aberrant adjustment will be more likely to trigger diseases such as cancers, kidney disease, central nervous system diseases, cardiovascular diseases, diabetes, viral infections and so on. What's worse, for the detection of miRNAs, their small size, high sequence similarity, low abundance and difficult extraction from cells impose great challenges in the analysis. Hence, it's necessary to fabricate accurate and sensitive biosensing platform for miRNAs detection. Up to now, researchers have developed many signal-amplification strategies for miRNAs detection, including hybridization chain reaction, nuclease amplification, rolling circle amplification, catalyzed hairpin assembly amplification and nanomaterials based amplification. These methods are typical, feasible and frequently used. In this review, we retrospect recent advances in signal amplification strategies for detecting miRNAs and point out the pros and cons of them. Furthermore, further prospects and promising developments of the signal-amplification strategies for detecting miRNAs are proposed.
Subject(s)
Biosensing Techniques/methods , MicroRNAs/isolation & purification , Nucleic Acid Amplification Techniques/methods , Biosensing Techniques/trends , Humans , MicroRNAs/genetics , Nanostructures/chemistry , Nucleic Acid Amplification Techniques/trends , Oligonucleotides/chemistry , Oligonucleotides/geneticsABSTRACT
Agnostic metagenomic next-generation sequencing (mNGS) has emerged as a promising single, universal pathogen detection method for infectious disease diagnostics. This methodology allows for identification and genomic characterization of bacteria, fungi, parasites, and viruses without the need for a priori knowledge of a specific pathogen directly from clinical specimens. Although there are increasing reports of mNGS successes, several hurdles need to be addressed, such as differentiation of colonization from infection, extraneous sources of nucleic acid, method standardization, and data storage, protection, analysis, and interpretation. As more commercial and clinical microbiology laboratories develop mNGS assays, it is important for treating practitioners to understand both the power and limitations of this method as a diagnostic tool for infectious diseases.
Subject(s)
Communicable Diseases/diagnosis , Communicable Diseases/microbiology , Metagenomics , Nucleic Acid Amplification Techniques/trends , Animals , Communicable Diseases/parasitology , HumansABSTRACT
Of the 40 million donations screened with Nucleic acid testing (NAT) between July 2001 and December 2015 in France, 20 HIV-positive, 13 HCV-positive and 17 HBV (HBV-NAT was initiated in 2005 and extended to the whole country in 2010) donations were discarded thanks to NAT. The main benefit in terms of discarded donations is related to HBV with a yield of 0.88 per million donations, which is 12.5 and 1.8 times higher than for HCV and HIV respectively. The main risk factor found in these donors during the post donation interview was having sex with men for males (n=11, all repeat blood donors), having a partner HCV positive (n=6) or at-risk partner (originated from endemic area or HBV positive) for HBV (n=8) for HIV, HCV and HBV, respectively. Although the mean viral load was high for HIV (5.6 log copies/mL) and HCV (7 log IU/mL), HBV cases show low level of DNA (1.8 log IU/mL) demonstrating the need of a highly sensitive NAT assay. Overall, the clinical benefit for recipients remains those related to the prevention of HIV contaminations since HCV avoided transmissions are extremely rare (only one case in the last 5 years thanks to NAT) and the potential infectivity of HBV-NAT only positive cases is questionable due to the low level of HBV DNA and the presence of anti-HBs in more than a half of DNA positive/HBsAg and anti-HBc negative donors.
Subject(s)
Blood Donors , Blood Safety/methods , Donor Selection/methods , Mass Screening/trends , Nucleic Acid Amplification Techniques/trends , Transfusion Reaction/prevention & control , Blood Safety/trends , DNA, Viral/blood , Donor Selection/organization & administration , Donor Selection/trends , Female , France/epidemiology , HIV Infections/blood , HIV Infections/diagnosis , HIV Infections/prevention & control , Hepatitis, Viral, Human/blood , Hepatitis, Viral, Human/diagnosis , Hepatitis, Viral, Human/prevention & control , Humans , Male , Mass Screening/methods , Mass Screening/organization & administration , RNA, Viral/blood , Retrospective Studies , Transfusion Reaction/epidemiology , Viremia/diagnosis , Viremia/prevention & controlABSTRACT
PCR-based methods are the most common technique for sex determination of birds. Although these methods are fast, easy and accurate, they still require special facilities that preclude their application outdoors. Consequently, there is a time lag between sampling and obtaining results that impedes researchers to take decisions in situ and in real time considering individuals' sex. We present an outdoor technique for sex determination of birds based on the amplification of the duplicated sex-chromosome-specific gene Chromo-Helicase-DNA binding protein using a loop-mediated isothermal amplification (LAMP). We tested our method on Griffon Vulture (Gyps fulvus), Egyptian Vulture (Neophron percnopterus) and Black Kite (Milvus migrans) (family Accipitridae). We introduce the first fieldwork procedure for sex determination of animals in the wild, successfully applied to raptor species of three different subfamilies using the same specific LAMP primers. This molecular technique can be deployed directly in sampling areas because it only needs a voltage inverter to adapt a thermo-block to a car lighter and results can be obtained by the unaided eye based on colour change within the reaction tubes. Primers and reagents are prepared in advance to facilitate their storage at room temperature. We provide detailed guidelines how to implement this procedure, which is simpler (no electrophoresis required), cheaper and faster (results in c. 90 min) than PCR-based laboratory methods. Our successful cross-species application across three different raptor subfamilies posits our set of markers as a promising tool for molecular sexing of other raptor families and our field protocol extensible to all bird species.
Subject(s)
Falconiformes/classification , Falconiformes/genetics , Nucleic Acid Amplification Techniques/methods , Sex Determination Analysis/methods , Animals , DNA Primers/genetics , DNA-Binding Proteins/genetics , Nucleic Acid Amplification Techniques/trends , Sequence Analysis, DNA , Sex ChromosomesABSTRACT
Recent advancements in DNA sequencing methodologies and sequence data analysis have revolutionised research in many areas of biology and medicine, including veterinary infection biology. New technology is poised to bridge the gap between the research and diagnostic laboratory. This paper defines the potential diagnostic value and purposes of next-generation sequencing (NGS) applications in veterinary infection biology and explores their compatibility with the existing validation principles and methods of the World Organisation for Animal Health. Critical parameters for validation and quality control (quality metrics) are suggested, with reference to established validation and quality assurance guidelines for NGS-based methods of diagnosing human heritable diseases. Although most currently described NGS applications in veterinary infection biology are not primary diagnostic tests that directly result in control measures, this critical reflection on the advantages and remaining challenges of NGS technology should stimulate discussion on its diagnostic value and on the potential to validate NGS methods and monitor their diagnostic performance.
Les avancées récentes enregistrées en matière de séquençage de l'ADN et d'analyse des données de séquences ont révolutionné la recherche dans de nombreux domaines de la biologie et de la médecine, notamment la biologie des maladies animales infectieuses. Ces nouvelles technologies vont permettre de combler le fossé qui séparait la recherche fondamentale du laboratoire de diagnostic. Après avoir défini l'intérêt diagnostique des applications du séquençage de nouvelle génération (SNG) ainsi que leurs finalités dans le domaine de la biologie des maladies animales infectieuses, les auteurs examinent leur compatibilité avec les méthodes et les principes actuels de validation recommandés par l'Organisation mondiale de la santé animale. Ils proposent quelques paramètres critiques de validation et de contrôle qualité (mesure de la qualité), en se référant aux lignes directrices de validation et d'assurance qualité des techniques diagnostiques basées sur le séquençage de nouvelle génération visant à détecter les maladies humaines héréditaires. Certes, la plupart des applications actuelles des méthodes de séquençage de nouvelle génération en biologie des maladies animales infectieuses ne constituent pas des tests de diagnostic primaire (dont dépendent directement les décisions de contrôle sanitaire) ; toutefois, l'analyse critique proposée par les auteurs sur les avantages de cette technologie et sur les difficultés restant à résoudre devrait ouvrir la voie à des discussions sur l'intérêt diagnostique des méthodes recourant au séquençage de nouvelle génération ainsi que sur les perspectives de validation et de contrôle de leurs performances diagnostiques.
Los recientes avances en los métodos de secuenciación del ADN y el análisis de los datos de secuencias han revolucionado la investigación en muchos ámbitos de la biología y la medicina, entre ellos la biología de las infecciones veterinarias. Las nuevas técnicas encierran la promesa de reducir la distancia entre el mundo de la investigación y los laboratorios de diagnóstico. Tras explicar el interés que pueden revestir las aplicaciones de la secuenciación de próxima generación y su posible uso con fines de diagnóstico de infecciones veterinarias, los autores examinan su compatibilidad con los principios y métodos de validación que tiene definidos la Organización Mundial de Sanidad Animal. Asimismo, proponen parámetros básicos para su validación y control de calidad (medición de la calidad), haciendo referencia a las pautas ya establecidas de validación y garantía de calidad de métodos de diagnóstico de enfermedades humanas hereditarias que reposan en técnicas de secuenciación de próxima generación. Aunque la mayoría de las aplicaciones de estas técnicas actualmente descritas en biología de las infecciones veterinarias no constituyen pruebas primarias de diagnóstico, esto es, cuyos resultados puedan inducir directamente medidas de control, esta crucial reflexión sobre las ventajas que entraña la secuenciación de próxima generación y los problemas que aún plantea debería alentar un debate sobre su interés para labores de diagnóstico y sobre la posibilidad de validar métodos basados en estas técnicas y de hacer un seguimiento de la eficacia diagnóstica que ofrezcan.
Subject(s)
Animal Diseases/diagnosis , High-Throughput Nucleotide Sequencing , Nucleic Acid Amplification Techniques/methods , Workflow , Animal Diseases/microbiology , Animal Diseases/virology , Animals , Nucleic Acid Amplification Techniques/trends , Quality Control , Reproducibility of ResultsABSTRACT
Detection and identification of food-borne pathogenic bacteria are key points for the assurance of microbiological food safety. Traditional culture-based methods are more and more replaced by or supplemented with nucleic acid based molecular techniques, targeting specific (preferably virulence) genes in the genomes. Internationally validated DNA amplification - most frequently real-time polymerase chain reaction - methods are applied by the food microbiological testing laboratories for routine analysis, which will result not only in shortening the time for results but they also improve the performance characteristics (e.g. sensitivity, specificity) of the methods. Beside numerous advantages of the polymerase chain reaction based techniques for routine microbiological analysis certain drawbacks have to be mentioned, such as the high cost of the equipment and reagents, as well as the risk of contamination of the laboratory environment by the polymerase chain reaction amplicons, which require construction of an isolated laboratory system. Lab-on-a-chip systems can integrate most of these laboratory processes within a miniaturized device that delivers the same specificity and reliability as the standard protocols. The benefits of miniaturized devices are: simple - often automated - use, small overall size, portability, sterility due to single use possibility. These miniaturized rapid diagnostic tests are being researched and developed at the best research centers around the globe implementing various sample preparation and molecular DNA amplification methods on-chip. In parallel, the aim of the authors' research is to develop microfluidic Lab-on-a-chip devices for the detection and identification of food-borne pathogenic bacteria.
Subject(s)
Bacteria/isolation & purification , Food Microbiology/instrumentation , Lab-On-A-Chip Devices , Nucleic Acid Amplification Techniques/methods , Food Safety , Foodborne Diseases/microbiology , Humans , Lab-On-A-Chip Devices/statistics & numerical data , Nucleic Acid Amplification Techniques/trends , Polymerase Chain Reaction , Reproducibility of ResultsABSTRACT
PURPOSE OF REVIEW: The purpose of this study is to describe the many advantages of PCR-based comprehensive chromosome screening (CCS) methodologies and the importance of extensive preclinical validation. RECENT FINDINGS: The rigorous preclinical validation of quantitative real-time (q)PCR-based CCS involved an initial validation on cell lines, followed by a blinded evaluation on embryos. Comparison with alternative platforms and a prospective randomized clinical trial demonstrate superior precision and improved sustained implantation and delivery rates. Preclinical validation of targeted PCR-based next-generation sequencing (NGS) has also demonstrated consistency in positive controls, equivalent accuracy to commonly used techniques, high resolution, increased throughput, the simultaneous detection of single gene disorders and triploidy, and the potential to decrease costs. Prospective randomized controlled trials are ongoing to validate this technique for clinical use. SUMMARY: CCS using PCR-based methodology improves implantation and delivery rates and allows for fresh embryo transfers. Other platforms are available to select euploid embryos; however, there are meaningful differences between techniques. PCR-based NGS technology may further enhance the utility of CCS for patients with infertility.
Subject(s)
Aneuploidy , Embryo Culture Techniques/methods , Embryo Transfer/methods , Genetic Testing/methods , High-Throughput Nucleotide Sequencing , Nucleic Acid Amplification Techniques , Blastocyst/cytology , Blastocyst/physiology , Embryo Implantation/physiology , Embryo Transfer/trends , Female , Genetic Testing/trends , High-Throughput Nucleotide Sequencing/trends , Humans , Nucleic Acid Amplification Techniques/trends , Pregnancy , Preimplantation Diagnosis , Sequence Analysis, DNAABSTRACT
Nucleic acid amplification is an essential process in biological systems. The in vitro adoption of this process has resulted in powerful techniques that underpin modern molecular biology. The most common tool is polymerase chain reaction (PCR). However, the requirement for a thermal cycler has somewhat limited applications of this classic nucleic acid amplification technique. Isothermal amplification, on the other hand, obviates the use of a thermal cycler because reactions occur at a single temperature. Isothermal amplification methods are diverse, but all have been developed from an understanding of natural nucleic acid amplification processes. Here we review current isothermal amplification methods as classified by their enzymatic mechanisms. We compare their advantages, disadvantages, efficiencies, and applications. Finally, we mention some new developments associated with this technology, and consider future possibilities in molecular engineering and recombinant technologies that may develop from an appreciation of the molecular biology of natural systems.
Subject(s)
Biomimetics/instrumentation , Biomimetics/methods , DNA/genetics , Nucleic Acid Amplification Techniques/instrumentation , Nucleic Acid Amplification Techniques/methods , Animals , Biomimetics/trends , Humans , Nucleic Acid Amplification Techniques/trendsABSTRACT
Next generation sequencing (NGS) has revolutionized virus discovery. Notwithstanding, a vertical pipeline, from sample preparation to data analysis, has not been available to the plant virology community. We developed a degenerate oligonucleotide primed RT-PCR method with multiple barcodes for NGS, and constructed VirFind, a bioinformatics tool specifically for virus detection and discovery able to: (i) map and filter out host reads, (ii) deliver files of virus reads with taxonomic information and corresponding Blastn and Blastx reports, and (iii) perform conserved domain search for reads of unknown origin. The pipeline was used to process more than 30 samples resulting in the detection of all viruses known to infect the processed samples, the extension of the genomic sequences of others, and the discovery of several novel viruses. VirFind was tested by four external users with datasets from plants or insects, demonstrating its potential as a universal virus detection and discovery tool.
Subject(s)
Insect Viruses/genetics , Insect Viruses/isolation & purification , Nucleic Acid Amplification Techniques/methods , Nucleic Acid Amplification Techniques/trends , Plant Viruses/genetics , Plant Viruses/isolation & purification , Algorithms , Animals , Base Sequence , DNA Barcoding, Taxonomic , DNA, Viral/classification , DNA, Viral/genetics , Insect Viruses/classification , Phylogeny , Plant Viruses/classification , RNA, Viral/classification , RNA, Viral/genetics , SoftwareABSTRACT
Historically, the use of cutting-edge molecular techniques to study immunological gene expression and related cellular pathways has been largely limited to model organisms. Few studies have been performed that quantify the molecular immunological responses of non-model species, especially in response to environmental factors, life-history events, or exposure to parasites. This dearth of information has largely occurred due to the lack of available non-model species-specific gene sequences and immunological reagents and also due to prohibitively expensive technology. However, with the rapid development of various sequencing and transcriptomic technologies, profiling the gene expression of non-model organisms has become possible. Technologies and concepts explored here include an overview of current technologies for quantifying gene expression, including: qPCR, multiplex branched DNA assays, microarrays, and profiling gene expression (RNA sequencing [RNA-Seq]) based on next-generation sequencing. Examples of the advancement of these technologies in non-model systems are discussed. Additionally, applications, limitations, and feasibility of the use of these methodologies in non-model systems to address questions in ecological immunology and disease-ecology are specifically addressed.
Subject(s)
Gene Expression Regulation/immunology , Nucleic Acid Amplification Techniques/methods , Nucleic Acid Amplification Techniques/trends , Animals , Animals, Wild , Ecosystem , Interdisciplinary StudiesABSTRACT
OBJECTIVE: To validate a next-generation sequencing (NGS)-based method for 24-chromosome aneuploidy screening and to investigate its applicability to preimplantation genetic screening (PGS). DESIGN: Retrospective blinded study. SETTING: Reference laboratory. PATIENT(S): Karyotypically defined chromosomally abnormal single cells and whole-genome amplification (WGA) products, previously analyzed by array comparative genomic hybridization (array-CGH), selected from 68 clinical PGS cycles with embryos biopsied at cleavage stage. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Consistency of NGS-based diagnosis of aneuploidy compared with either conventional karyotyping of single cells or array-CGH diagnoses of single blastomeres. RESULT(S): Eighteen single cells and 190 WGA products from single blastomeres, were blindly evaluated with the NGS-based protocol. In total, 4,992 chromosomes were assessed, 402 of which carried a copy number imbalance. NGS specificity for aneuploidy call (consistency of chromosome copy number assignment) was 99.98% (95% confidence interval [CI] 99.88%-100%) with a sensitivity of 100% (95% CI 99.08%-100%). NGS specificity for aneuploid embryo call (24-chromosome diagnosis consistency) was 100% (95% CI 94.59%-100%) with a sensitivity of 100% (95% CI 97.39%-100%). CONCLUSION(S): This is the first study reporting extensive preclinical validation and accuracy assessment of NGS-based comprehensive aneuploidy screening on single cells. Given the high level of consistency with an established methodology, such as array-CGH, NGS has demonstrated a robust high-throughput methodology ready for clinical application in reproductive medicine, with potential advantages of reduced costs and enhanced precision.
Subject(s)
Aneuploidy , Nucleic Acid Hybridization , Prenatal Diagnosis/standards , Prenatal Diagnosis/trends , Adult , Female , High-Throughput Nucleotide Sequencing/standards , High-Throughput Nucleotide Sequencing/trends , Humans , Middle Aged , Nucleic Acid Amplification Techniques/standards , Nucleic Acid Amplification Techniques/trends , Nucleic Acid Hybridization/methods , Pregnancy , Randomized Controlled Trials as Topic/standards , Randomized Controlled Trials as Topic/trends , Retrospective Studies , Single-Blind MethodABSTRACT
Since its invention in 2000, loop-mediated isothermal amplification (LAMP) assay has been one of the most extensively used molecular diagnostic tools in bio-medical fields due to the rapidity, accuracy, and cost-effectiveness of the technique. This technique has also earned popularity in aquaculture disease diagnosis. Aquaculture, as a result of its rapid intensification and expansion, experiences increased infectious disease occurrences. For maintenance of economic viability, rapid, sensitive and efficient diagnosis of disease causing agents is an important step prior to undertaking effective prevention and control measures in aquaculture. Constraints on time and expertise required for conventional biochemical, serological and polymerase chain reaction (PCR)-based techniques offer avenues in adoption of the LAMP by the aquaculturists at field conditions. This assay has been successfully applied in detection of several bacterial, viral and parasitic pathogens causing serious diseases in aquaculture. In this review, we endeavored to accommodate the LAMP methodology with its different recent improvements and an overview of its application for the detection of aquaculture-associated pathogens.
Subject(s)
Aquaculture , Bacterial Infections/veterinary , Molecular Diagnostic Techniques/methods , Nucleic Acid Amplification Techniques/methods , Parasitic Diseases, Animal/diagnosis , Veterinary Medicine/methods , Virus Diseases/veterinary , Animals , Bacterial Infections/diagnosis , Molecular Diagnostic Techniques/trends , Nucleic Acid Amplification Techniques/trends , Veterinary Medicine/trends , Virus Diseases/diagnosisABSTRACT
Loop-mediated isothermal amplification (LAMP) is an established technology that continues to attract the attention of researchers in many fields. Research and development efforts on LAMP technology in recent years have focused on two major areas; first, the study of its clinical application as an approved in vitro diagnostics tool in Japan and certain other countries; and second, research aimed at further simplifying the LAMP test process. This review provides an overview of the status of LAMP on these two topics by summarizing research work conducted, in the main, after our previous review article.